Nearly a third of inflammatory bowel disease (IBD) patients present in childhood or adolescence, with epidemiological and natural history studies clearly demonstrating a rising incidence in this population. Although early-onset disease has a distinct phenotype, such as more extensive disease at onse
The incidence of childhood inflammatory bowel disease in Wales
β Scribed by Kamal Hassan; Fiona J. Cowan; Huw R. Jenkins
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 58 KB
- Volume
- 159
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Around 1 in 4 patients with inflammatory bowel disease (IBD) present in childhood, the majority around the time of their pubertal growth spurt. This presents challenges over and above those of managing IBD in adults as this period is a time of dramatic psychological and physical transition for a chi
## Background: Adalimumab is effective for adults with moderate to severe crohn's disease (cd). data in children with inflammatory bowel disease (ibd) is sparse. we aim to evaluate pediatric ibd response to adalimumab. ## Methods: We conducted a retrospective chart review of pediatric ibd patient
## Background: The incidence of inflammatory bowel disease (IBD) may be lower among people of African descent than Caucasians. However, incidence studies among the former are uncommon and are often limited by incomplete case ascertainment or uncertainty about the size of the "at-risk" population.
Background: Inflammatory bowel disease (IBD) is a polygenetic disorder. Our group previously showed that a variant within the CXCL9 gene is associated with pediatric Crohn's disease. As CXCL9, CXCL10, and CXCL11 are the 3 ligands to the receptor CXCR3, the aim of this study was to investigate the co